Springer

SHERPA: Unknown

People

  1. Offit
    Offit
  2. Robson
    Robson
  3. Stadler
    Stadler
  4. Shia
    Shia
  5. Weiser
    Weiser
  6. Joseph
    Joseph
  7. Hamilton
    Hamilton
  8. Markowitz
    Markowitz
  9. Vakiani
    Vakiani
  10. Garcia Aguilar
    Garcia Aguilar

Groups

  1. Clinical Genetics Service (60)
  2. Department of Medicine (60)
  3. Population Sciences Research Program (60)
  4. Solid Tumor Oncology Division (60)
  5. Survivorship Research (48)
  6. GSK Faculty (45)
  7. Breast Medicine Service (24)
  8. Surgery (23)
  9. Center for Pancreatic Cancer Research (20)
  10. Department of Pathology and Laboratory Medicine (17)
Search Within
  1. "Clinical Genetics Service"
Formats
  1. Journal Article (45)
  2. Meeting Abstract (12)
  3. Book Section (1)
  4. Miscellaneous (1)
  5. Review (1)
Groups
  1. Clinical Genetics Service (60)
  2. Department of Medicine (60)
  3. Population Sciences Research Program (60)
  4. Solid Tumor Oncology Division (60)
  5. Survivorship Research (48)
  6. GSK Faculty (45)

More Groups

People
  1. Kenneth Offit (44)
  2. Mark Robson (24)
  3. Zsofia Stadler (19)
  4. Jinru Shia (10)
  5. Liying Zhang (8)
  6. Martin Weiser (8)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (2)
  6. 2019 (3)

More Years

Publications
  1. Breast Cancer Research and Treatment (21)
  2. Familial Cancer (15)
  3. Annals of Surgical Oncology (6)
  4. Annals of Behavioral Medicine (5)
  5. Human Genetics (4)
  6. Advances in Experimental Medicine and Biology (1)

More Publications

Results (60)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue
    Journal Article

    Adank, M. A.; Brogi, E.; Bogomolniy, F.; Wadsworth, E. A.; Lafaro, K. J.; Yee, C. J.; Kirchhoff, T.; Meijers-Heijboer, E. J.; Kauff, N. D.; Boyd, J.; more...
    Familial Cancer (2006)

    Fulltext@MSK | Save
  • Implications of ductal carcinoma in situ in predicting BRCA status in Ashkenazi Jewish women
    Meeting Abstract

    Sukumvanich, P.; Wadsworth, E.; Nafa, K.; Kolachana, P.; Borgen, P. I.; Robson, M. E.; Offit, K.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Emerging ethical issues in cancer genetic testing
    Meeting Abstract

    Offit, K.
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Radiation exposure and breast cancer risk for BRCA mutation carriers
    Meeting Abstract

    Goldfrank, D. J.; Chuai, S.; Cajal, T. R. Y.; Lee, J. B.; Alonso, M. C.; Diez, O.; Baiget, M.; Kauff, N. D.; Offit, K.; Bernstein, J. L.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds
    Journal Article

    Siddiqui, R.; Onel, K.; Facio, F.; Nafa, K.; Diaz, L. R.; Kauff, N.; Huang, H.; Robson, M.; Ellis, N.; Offit, K.
    Familial Cancer (2005)

    Fulltext@MSK | Save
  • The genetics of familial lymphomas
    Journal Article

    Siddiqui, R.; Onel, K.; Facio, F.; Offit, K.
    Current Oncology Reports (2004)

    Fulltext@MSK | Save
  • Hereditary ovarian cancer in Ashkenazi Jews
    Journal Article

    Robles-Díaz, L.; Goldfrank, D.; Kauff, N.; Robson, M.; Offit, K.
    Familial Cancer (2004)

    Fulltext@MSK | Save
  • A636P testing in Ashkenazi Jews
    Journal Article

    Guillem, J.; Moore, H. G.; Palmer, C.; Glogowski, E.; Finch, R.; Nafa, K.; Markowitz, A. J.; Offit, K.; Ellis, N. A.
    Familial Cancer (2004)

    Fulltext@MSK | Save
  • Impact of tamoxifen on the risk of metachronous contralateral breast cancer in women with germline mutations of BRCA1 or BRCA2
    Meeting Abstract

    Robson, M. E.; Satagopan, J.; Hudis, C. A.; Boyd, J.; Offit, K.
    Breast Cancer Research and Treatment (2002)

    Fulltext@MSK | Save
  • Risk of ipsilateral recurrence (IBTR) and metachronous contralateral breast cancer (CBC) after breast conservation therapy (BCT) in women with germline BRCA1 or BRCA2 mutations
    Meeting Abstract

    Robson, M.; Roberge, D.; Satagopan, J.; Chappuis, P.; Boyd, J.; Offit, K.; Foulkes, W.
    Breast Cancer Research and Treatment (2000)

    Fulltext@MSK | Save